Publications by authors named "Naim Alkhouri"

176Publications

A perspective on RNA interference-based therapeutics for metabolic liver diseases.

Expert Opin Investig Drugs 2021 Jan 20. Epub 2021 Jan 20.

Division of Gastroenterology and Hepatology, Indiana University School of Medicine , Indianapolis, IN, USA.

View Article and Find Full Text PDF
January 2021

Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Non-alcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2021 Jan 9. Epub 2021 Jan 9.

Arizona liver institute, Scottsdale, Arizona, USA.

View Article and Find Full Text PDF
January 2021

Shear wave elastography reveals a high prevalence of liver fibrosis in overweight or obese Hispanic youth.

J Ultrason 2020 Nov 28;20(82):e162-e168. Epub 2020 Sep 28.

Texas Liver Institute and University of Texas Health, Department of Pediatric Gastroenterology, San Antonio, TX, United States.

View Article and Find Full Text PDF
November 2020

Sex differences in age at wait-list registration for liver transplantation with nonalcoholic steatohepatitis as primary indication.

Clin Transplant 2020 Dec 6:e14163. Epub 2020 Dec 6.

Department of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article and Find Full Text PDF
December 2020

Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.

Metabolism 2020 Dec 1;116:154457. Epub 2020 Dec 1.

Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Center for Microbiome and Human Health, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA. Electronic address:

View Article and Find Full Text PDF
December 2020

Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver Diseases.

Hepatology 2020 Sep 26. Epub 2020 Sep 26.

Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, 78215, United States.

View Article and Find Full Text PDF
September 2020

Driving Nonalcoholic Steatohepatitis Forward Using the FibroScan Aspartate Aminotransferase Score, But Obey the Traffic Lights.

Hepatology 2020 Aug 5. Epub 2020 Aug 5.

Division of Digestive and Liver Diseases, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article and Find Full Text PDF
August 2020

Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists.

Expert Opin Emerg Drugs 2020 09 12;25(3):251-260. Epub 2020 Aug 12.

Liver Institute Northwest , Seattle, WA, USA.

View Article and Find Full Text PDF
September 2020

Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2.

ACG Case Rep J 2020 Jun 22;7(6):e00412. Epub 2020 Jun 22.

Division of Gastroenterology, Texas Liver Institute, University of Texas Health, San Antonio, TX.

View Article and Find Full Text PDF
June 2020

Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?

Clin Diabetes Endocrinol 2020 5;6. Epub 2020 Jun 5.

Research Division, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215 USA.

View Article and Find Full Text PDF
June 2020

Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma.

Clin Gastroenterol Hepatol 2020 Oct 20;18(11):2600-2608.e1. Epub 2020 Mar 20.

Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

View Article and Find Full Text PDF
October 2020